Click
here to close Hello! We notice that
you are using Internet Explorer, which is not supported by Echinobase
and may cause the site to display incorrectly. We suggest using a
current version of Chrome,
FireFox,
or Safari.
Front Nutr
2021 Sep 13;8:763692. doi: 10.3389/fnut.2021.763692.
Show Gene links
Show Anatomy links
Sea Cucumber Intestinal Peptide Induces the Apoptosis of MCF-7 Cells by Inhibiting PI3K/AKT Pathway.
Wei W
,
Fan XM
,
Jia SH
,
Zhang XP
,
Zhang Z
,
Zhang XJ
,
Zhang JX
,
Zhang YW
.
Abstract
Sea cucumbers are one of many marine echinoderm animals that contain valuable nutrients and medicinal compounds. The bioactive substances in sea cucumbers make them have promising biological and pharmacological properties, including antioxidant, anti-bacterial, and anti-tumor effects. In this study, sea cucumber intestinal peptide (SCIP) is a small molecular oligopeptide (<1,000 Da) extracted from sea cucumber intestines hydrolyzed by alkaline protease. The analysis of amino acid composition showed that hydrophobic amino acids and branched-chain amino acids were rich in SCIP. Nowadays, although increasing studies have revealed the biological functions of the sea cucumber active substances, there are few studies on the function of SCIP. Furthermore, due to the anti-cancer activity being an essential characteristic of sea cucumber active substances, we also investigated the anti-cancer potential and the underlying mechanism of SCIP in vivo and in vitro. The results indicate that SCIP inhibits the growth of MCF-7 tumor cells in zebrafish and increases the apoptosis of human breast cancer MCF-7 cells. Further mechanism studies confirm that SCIP promotes the expression of apoptosis-related proteins and thus promotes the breast cancer cells (MCF-7) apoptosis via inhibition of PI3K/AKT signal transduction pathway.
Figure 1. The molecular weight distribution of SCIP investigated by high-performance liquid chromatography (HPLC).
Figure 2. Sea cucumber intestinal peptide inhibits the growth of tumor cells in zebrafish. The wild-type AB zebrafish do not produce red fluorescence. CM-Dil labeled cells injected into the yolk sac of zebrafish can produce red fluorescence at a certain wavelength. The total fluorescence intensity is positively correlated with the number of cancer cells. (A) Control group; (B) Model group; (C) Capecitabine group, administration of 20 μg/ml capecitabine by water-soluble; (D) Low concentration SCIP group, administration of 27.8 μg/ml SCIP by water-soluble; (E) Middle concentration SCIP group, administration of 83.3 μg/ml SCIP by water-soluble; (F) High concentration SCIP group, administration of 250 μg/ml SCIP by water-soluble. “*” means that the experimental group was significant. On the contrary, the “#” means that the experimental group is not significant.
Figure 3. SCIP inhibits the proliferation of MCF-7 cells. Cells were synchronized and incubated with SCIP at various concentrations (27.8, 83.3, and 250 μg/ml) for 24, 48, and 72 h, respectively. Then, the cell samples were harvested and subjected to investigate the proliferation of MCF-7 cells by MTT analysis. Each value was expressed as mean ± SD for three independent experiments by GraphPad Prism Software Version 5.0. *p < 0.05 was considered a significant difference when compared with 24 h, and #p < 0.05 was considered a significant difference compared to the low dose group.
Figure 4. SCIP improves the apoptosis of MCF-7. (I) The apoptosis level of MCF-7 cells was determined by flow cytometry analysis. MCF-7 Cells were cultured and incubated with 20 μg/ml of capecitabine and various concentrations of SCIP (27.8, 83.3, and 250 μg/ml) for 12 h, then, MCF-7 cells were stained with annexin V and PI, and flow cytometry was carried out to detect its apoptosis rate. (II) The expression of apoptosis-related proteins was investigated by western blots. MCF-7 cells were cultured and incubated with 20 μg/ml of capecitabine and various concentrations of SCIP (27.8, 83.3, and 250 μg/ml) for 12 h; After the treatment, the cells were collected to extract the total proteins and performed the western blot analysis to measure the expression of apoptosis proteins. a: Control group, MCF-7 cells were stimulated by PBS; b: Capecitabine group, MCF-7 cells were incubated by 20 μg/ml of capecitabine for 12 h; c: Low dose SCIP group, MCF-7 cells were incubated by 27.8 μg/ml of SCIP for 12 h; d: Moderate dose SCIP group, MCF-7 cells were incubated by 83.3 μg/ml of SCIP for 12 h; f: High dose SCIP group, MCF-7 cells were incubated by 250 μg/ml of SCIP for 12 h.
Figure 5. SCIP promotes the apoptosis of MCF-7 by activation of PI3K/AKT signaling pathway. (I) MCF-7 cells were treated with various concentrations of SCIP (0, 27.8, 83.3, and 250 μg/ml) for 24 h, then collected the cells to extract the total proteins and western blots were used to investigate the expression of total AKT (t-AKT), p-AKT, t-PI3k, and p-PI3k, respectively (n = 3). (II) MCF-7 cells were pretreated with wortmannin for 1 h, then incubated with SCIP (0, 27.8, 83.3, and 250 μg/ml) for 24 h. After treatment, the MCF-7 cells were harvested to detect the expression of t-AKT, p-AKT, Clv.caspase-9, and Clv.caspase-3 (n = 3).
Aminin,
Anticancer activity of sea cucumber triterpene glycosides.
2015,
Pubmed
,
Echinobase
Araki,
Mechanism of resistance to endocrine therapy in breast cancer: the important role of PI3K/Akt/mTOR in estrogen receptor-positive, HER2-negative breast cancer.
2018,
Pubmed
Berns,
A functional genetic approach identifies the PI3K pathway as a major determinant of trastuzumab resistance in breast cancer.
2007,
Pubmed
Bordbar,
High-value components and bioactives from sea cucumbers for functional foods--a review.
2011,
Pubmed
,
Echinobase
Chalamaiah,
Fish protein hydrolysates: proximate composition, amino acid composition, antioxidant activities and applications: a review.
2012,
Pubmed
Ciruelos Gil,
Targeting the PI3K/AKT/mTOR pathway in estrogen receptor-positive breast cancer.
2014,
Pubmed
Costa,
Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review.
2018,
Pubmed
Cusimano,
A Synthetic Derivative of Antimicrobial Peptide Holothuroidin 2 from Mediterranean Sea Cucumber (Holothuria tubulosa) in the Control of Listeria monocytogenes.
2019,
Pubmed
,
Echinobase
Gao,
Proximate composition and nutritional quality of deep sea growth sea cucumbers (Stichopus japonicus) from different origins.
2016,
Pubmed
,
Echinobase
Gao,
Overview of recent advances in liposomal nanoparticle-based cancer immunotherapy.
2019,
Pubmed
Garcia-Candela,
Antiviral activity of the sea cucumber tegument extract (Pattalus mollis) on human rotavirus A (RVA).
2021,
Pubmed
,
Echinobase
Guerrero-Zotano,
PI3K/AKT/mTOR: role in breast cancer progression, drug resistance, and treatment.
2016,
Pubmed
Guo,
Antioxidant and anti-aging effects of a sea cucumber protein hydrolyzate and bioinformatic characterization of its composing peptides.
2020,
Pubmed
,
Echinobase
Janakiram,
Sea Cucumbers Metabolites as Potent Anti-Cancer Agents.
2015,
Pubmed
,
Echinobase
Jia,
Apatinib suppresses the Proliferation and Apoptosis of Gastric Cancer Cells via the PI3K/Akt Signaling Pathway.
2019,
Pubmed
Kalpage,
Cytochrome c phosphorylation: Control of mitochondrial electron transport chain flux and apoptosis.
2020,
Pubmed
Khotimchenko,
Pharmacological Potential of Sea Cucumbers.
2018,
Pubmed
,
Echinobase
Masood,
Activation of Caspase-3 by Terpenoids and Flavonoids in Different Types of Cancer Cells.
2020,
Pubmed
Mayer,
The PI3K/AKT Pathway as a Target for Cancer Treatment.
2016,
Pubmed
Nguyen,
Frondoside A from sea cucumber and nymphaeols from Okinawa propolis: Natural anti-cancer agents that selectively inhibit PAK1 in vitro.
2017,
Pubmed
,
Echinobase
Noorolyai,
The relation between PI3K/AKT signalling pathway and cancer.
2019,
Pubmed
Pangestuti,
Medicinal and health benefit effects of functional sea cucumbers.
2018,
Pubmed
,
Echinobase
Rad,
Cinnamomum cassia Suppresses Caspase-9 through Stimulation of AKT1 in MCF-7 Cells but Not in MDA-MB-231 Cells.
2015,
Pubmed
Sajwani,
Frondoside A is a potential anticancer agent from sea cucumbers.
2019,
Pubmed
,
Echinobase
Sharma,
PI3K/Akt/mTOR Intracellular Pathway and Breast Cancer: Factors, Mechanism and Regulation.
2017,
Pubmed
Tian,
PE, a new sulfated saponin from sea cucumber, exhibits anti-angiogenic and anti-tumor activities in vitro and in vivo.
2005,
Pubmed
,
Echinobase
Ullah,
Green-Synthesized Silver Nanoparticles Induced Apoptotic Cell Death in MCF-7 Breast Cancer Cells by Generating Reactive Oxygen Species and Activating Caspase 3 and 9 Enzyme Activities.
2020,
Pubmed
Verret,
Efficacy of PI3K inhibitors in advanced breast cancer.
2019,
Pubmed
Wargasetia,
Mechanisms of cancer cell killing by sea cucumber-derived compounds.
2017,
Pubmed
,
Echinobase
Wen,
Chemical composition and nutritional quality of sea cucumbers.
2010,
Pubmed
,
Echinobase
Yang,
Silica nanoparticles induced intrinsic apoptosis in neuroblastoma SH-SY5Y cells via CytC/Apaf-1 pathway.
2017,
Pubmed
Yuan,
Sea cucumber extract TBL-12 inhibits the proliferation, migration, and invasion of human prostate cancer cells through the p38 mitogen-activated protein kinase and intrinsic caspase apoptosis pathway.
2019,
Pubmed
,
Echinobase
Zeng,
Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
2013,
Pubmed
Zhao,
Saponins from Sea Cucumber and Their Biological Activities.
2018,
Pubmed
,
Echinobase